Kim Insook, Morimura Keiichirou, Shah Yatrik, Yang Qian, Ward Jerrold M, Gonzalez Frank J
Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Carcinogenesis. 2007 May;28(5):940-6. doi: 10.1093/carcin/bgl249. Epub 2006 Dec 20.
The farnesoid X receptor (FXR) controls the synthesis and transport of bile acids (BAs). Mice lacking expression of FXR, designated Fxr-null, have elevated levels of serum and hepatic BAs and an increase in BA pool size. Surprisingly, at 12 months of age, male and female Fxr-null mice had a high incidence of degenerative hepatic lesions, altered cell foci and liver tumors including hepatocellular adenoma, carcinoma and hepatocholangiocellular carcinoma, the latter of which is rarely observed in mice. At 3 months, Fxr-null mice had increased expression of the proinflammatory cytokine IL-1beta mRNA and elevated beta-catenin and its target gene c-myc. They also had increased cell proliferation as revealed by increased PCNA mRNA and BrdU incorporation. These studies reveal a potential role for FXR and BAs in hepatocarcinogenesis.
法尼酯X受体(FXR)控制胆汁酸(BAs)的合成与运输。缺乏FXR表达的小鼠(称为Fxr基因敲除小鼠)血清和肝脏中的胆汁酸水平升高,胆汁酸池大小增加。令人惊讶的是,在12月龄时,雄性和雌性Fxr基因敲除小鼠发生退行性肝损伤、细胞灶改变和肝肿瘤(包括肝细胞腺瘤、癌和肝内胆管细胞癌)的发生率很高,后者在小鼠中很少见。在3月龄时,Fxr基因敲除小鼠促炎细胞因子IL-1β mRNA的表达增加,β-连环蛋白及其靶基因c-myc水平升高。PCNA mRNA增加和BrdU掺入增加表明它们的细胞增殖也增加。这些研究揭示了FXR和胆汁酸在肝癌发生中的潜在作用。